Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus.
Manzi G, Benza RL, Argiento P, Casu G, Corda M, Correale M, D'Alto M, Galgano G, Garascia A, Ghio S, Gomberg-Maitland M, Mulé M, Paciocco G, Papa S, Prati D, Preston IR, Raineri C, Romeo E, Scelsi L, Stolfo D, Vitulo P, White RJ, Badagliacca R, Vizza CD.
Manzi G, et al. Among authors: vizza cd.
Vascul Pharmacol. 2024 Dec;157:107432. doi: 10.1016/j.vph.2024.107432. Epub 2024 Sep 10.
Vascul Pharmacol. 2024.
PMID: 39265796
Review.